-
Mercati
-
Azioni
Sustainable finance2025 Euronext ESG Trends ReportLeggi tuttoA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indici
Access the white paperInvesting in the future of Europe with innovative indicesLeggi tuttoThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF
The European market place for ETFsEuronext ETF EuropeLeggi tuttoInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fondi
-
Obbligazioni
European Defence BondsGroupe BPCE lists the first bondLeggi tuttoFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Prodotti strutturati
-
Derivati
Where European Government Bonds Meet the FutureFixed Income derivativesLeggi tuttoTrade mini bond futures on main European government bonds
-
Commodities
- Panoramica
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Consegna e liquidazione
- Specifiche e disposizioni
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLeggi tuttoEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Documenti e risorse
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLeggi tuttoJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Adocia
Identification
Nome strumento
ADOCIA
Ticker
ADOC
Codice ISIN
FR0011184241
Mercato
Euronext
Borsa
Paris
Products family
Stocks
ICB
Biotechnology
Activity description
Adocia est spécialisé dans la recherche et le développement de produits biothérapeutiques destinés à la régénération des tissus et au traitement de maladies chroniques.
A fin juin 2011, le groupe dispose d’un portefeuille de 4 produits en développement clinique (dont 2 en phase II ; PDGF-BB pour le traitement des ulcères du pied diabétique et HinsBet, insuline humaine à action rapide pour le traitement du diabète).
Indirizzo web
www.adocia.com
Operation
Data IPO
Lun 20/02/2012
Tipologia IPO
Introduction par offre publique
Tipologia IPO
Initial Public offering
Categoria
IPO
Calendario
LISTING DATE: 14/02/2012
TRADING DATE: 20/02/2012
Intervallo di prezzo
Fourchette de prix indicative : 13,00 EUR - 15,88 EUR par action (le "Prix de l'Offre")